Rainbow Children’s Medicare Ltd - Steady Performance, Lower Seasonality; Maintain BUY!
In Line Revenue Performance: Rainbow delivered revenue broadly in line with expectations, growing 7% YoY and recovering 26% sequentially.
130 Views
Rainbow Children's Medicare Ltd - Asset-Light Model: Excellence, Scale...
We initiate coverage on Rainbow Children’s Medicare with a BUY recommendation and a DCFbased Target Price (TP) of Rs 1,625/share (EV/EBITDA of 23x...
266 Views
Rainbow Children's Medicare - In-Line Quarter; Execution Delay a Slight Dampener
Ramp up in new hospitals remains strong with breakeven expected for Hyderabad hospitals (commissioned during Q4FY24) within the next quarter.
144 Views
Rainbow Children's Medicare - Leading the Way with Sustainable Growth
The company witnessed moderate FY24 (8% YoY EBITDA growth) due to weak seasonality related infections, a high COVID base and commissioning of new...
216 Views
Axis Diwali Muhurat Picks: SAMVAT 2082
Samvat 2081 was a challenging year for the Indian equity market, with the Indian market underperforming global and emerging markets for the first...
445 Views